Doseology proposes 75,268-share settlement for $13,548.39 consulting compensation

Sep 23, 2026 22:16 (30d ago)

Verifying

Doseology proposes issuing common shares to settle accrued compensation owed to a former consultant.
75,268 shares are proposed at $0.18 each, covering $13,548.39 in compensation.
Daniel Vice resigned as a Doseology director effective September 17, 2026.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.